SPIRIT 2025 Statement
An-Wen Chan(University of Toronto), Asbjørn Hróbjartsson(University of Southern Denmark), Martin Offringa(Hospital for Sick Children), Lehana Thabane(Impact), Robert Golub(American Medical Association), Brennan C Kahan(MRC Clinical Trials Unit at UCL), Dawn P. Richards(Robarts Clinical Trials), R. Taylor(University of Oxford), Nita Bhandari, Sophie Staniszewska(University of Warwick), Sally Hopewell(University of Oxford), Philippe Ravaud(Inserm), Jesse A. Berlin(Janssen (Belgium)), Elizabeth Loder(Brigham and Women's Hospital), Runcie C.W. Chidebe(University of Miami), Kenneth F. Schulz(University of North Carolina at Chapel Hill), Diana Elbourne(London School of Hygiene & Tropical Medicine), Ian R. White(MRC Clinical Trials Unit at UCL), Steven N. Goodman(Stanford University), R. Tunn(Oxford BioMedica (United Kingdom)), Isabelle Boutron(Inserm), Dean Fergusson(Ottawa Hospital), Steff Lewis(University of Edinburgh), David Moher(University of Ottawa), Sarah E Lamb(University of Exeter), John P. A. Ioannidis(Innovative Research (United States)), Sunita Vohra(University of Alberta), Nancy J. Butcher(University of Toronto), David L. Schriger(University of California, Los Angeles), Nandi Siegfried(South African Medical Research Council), Marion Campbell(Hairmyres Hospital), Frank W. Rockhold(Amyloidosis Foundation), Tammy Hoffmann(Bond University), Rachel L Knowles(Great Ormond Street Hospital), David Torgerson(University of York), Michael Berkwits, Gary S. Collins(NIHR Birmingham Biomedical Research Centre), Rakesh Aggarwal(Sanjay Gandhi Post Graduate Institute of Medical Sciences)
Cited by 84